Parameters of Specific Antibody Interaction with Pgp in T-Cell Leukemia Jurkat Cells
Abstract
Special features of Pgp expression evaluation by flow cytometry were investigated. Indexes of interaction of FITC-conjugated Becton Dickinson Pharmingen monoclonal antibodies to external Pgp epitope (clone 17F9) were analyzed depending on the cell concentration (400000 to 3000000 cells/ml) and the specific antibody concentration (5, 10 and 20 μl of the market product solution per 300 μl of the cell suspension). Results. 1. Optimal condition of incubation with the antibodies was revealed - after the cell fixation in 4% formaldehyde. 2. Character of the increase of the cell fluorescence average intensity in the suspension totally according to the concentration of the Pgp-specific antibodies did not depend on the number of the cells. 3. Both the absolute value of the average intensity of the cell specific fluorescence as well as cell number out of the isotypic control fluorescence region depended on the ratio of the cell number to monoclonal antibody concentration. Conclusion. 1. It was shown that Pgp was practically expressed in all Jurkat cells. 2. By the Pgp expression level, the Jurkat cell culture was sufficiently homogeneous and stable in various passages. 3. Jurkat cells could be used as test culture in estimation of the market antibody activity. 4. For immunofluorescent assay of the Pgp expression in human tumor biopsy specimens, it is necessary to use not less than three concentrations of the specific antibodies, not less than three concentrations of the cells in the suspension as well as concurrent assay of the cell culture characterized previously. In particular, for investigated Pgp monoclonal antibodies, it is possible to use Jurkat cell culture. It allows revealing not only the fact of the Pgp expression but the level of the expression as well, i. e. to estimate severity of multidrug resistance phenotype.
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 13.05.2020
All authors have read and approved the final manuscript.
Peer review info:
"Antibiot Khimioter = Antibiotics and Chemotherapy" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
About the Authors
T. A. Bogush
Russian N.N. Blokhin Memorial Cancer Research Center Russian Academy of Medical Sciences, Moscow
Russian Federation
E. A. Dudko
Russian N.N. Blokhin Memorial Cancer Research Center Russian Academy of Medical Sciences, Moscow
Russian Federation
E. A. Bogush
Russian N.N. Blokhin Memorial Cancer Research Center Russian Academy of Medical Sciences, Moscow
Russian Federation
A. YU. Baryshnikov
Russian N.N. Blokhin Memorial Cancer Research Center Russian Academy of Medical Sciences, Moscow
Russian Federation
References
1. Widmer N. Functional consequence of MDR1 expression on imatinib intracellular concentrations. Blood 2003; 102: 3: 1142-1144.
2. Nagashima S. BCRP/ABCG2 levels account for the resistance to topoisomerase inhibitors and reversal effects by gefitinib in non-small-cell lung cancer. Cancer Chemother Pharmacol 2006; 58: 5: 594-600.
3. Yague E., Armesilla A., Harrison G. et al. P-Glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J Biol Chem 2003; 278: 12: 10344-10352.
4. Zhao Y., Yu L., Lou F. et al. The clinical significance of lung resistance-related protein gene (lrp), multidrug resistance-associated protein gene(mrp) and mdr-1/p170 expression in acute leukemia. Zhonghua Nei Ke Za Zhi 1999; 38: 11: 760-763.
5. Schwarzenbach H. A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues. Anal Biochem 2002; 308: 1: 26-33.
6. Beck W., Grogan T., Willman C. et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 1996; 56: 13: 3010-3020.
7. Zhang H., Zhang W., Li F. Prognostic significance of MDR-1 P-glycoprotein expression in breast cancer. Journal of Nanjing Medical University 2008; 22: 3: 148-152.
For citations:
Bogush T.A.,
Dudko E.A.,
Bogush E.A.,
Baryshnikov A.Yu.
Parameters of Specific Antibody Interaction with Pgp in T-Cell Leukemia Jurkat Cells. Antibiot Khimioter = Antibiotics and Chemotherapy. 2009;54(1-2):3-9.
(In Russ.)
Views:
341